Friends of Cancer Research shared a post on LinkedIn:
“Early endpoints are an important tool for accelerating the development of promising therapies and getting treatments to patients faster.
Friends of Cancer Research is hosting a public meeting, Modernizing Oncology Endpoints: Pathways for Evidence and Policy, to review the current landscape and application of evolving early endpoints—such as ctDNA and AI-based tumor assessments—and explore how they may improve trial efficiency and inform regulatory decision-making.
View our agenda and register now to secure your spot.”
More from Friends of Cancer Research.